Pentair (PNR) director Form 4 shows 6,558-share option exercise and sale

Rhea-AI Filing Summary

Pentair plc director reports option exercise and share sale. A Pentair plc (PNR) director filed a Form 4 disclosing that on 12/01/2025 they exercised director stock options for 6,558 common shares at an exercise price of $32.83 per share and sold 6,558 common shares at a price of $104.33 per share. The transactions were made under a Rule 10b5-1 trading plan adopted on February 10, 2025 for financial planning purposes. After these transactions, the director beneficially owned 31,192 common shares directly, 1,659.571 common shares in the form of restricted stock units, and 1,976.605 phantom stock units that are designed to convert into common shares on a one-for-one basis and be settled in Pentair common shares in accordance with the reporting person’s irrevocable election.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GLENN T MICHAEL

(Last) (First) (Middle)

5500 WAYZATA BLVD., SUITE 900

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PENTAIR plc [ PNR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	12/01/2025		M(1)		6,558	A	$32.83	37,750	D
Common Shares	12/01/2025		S		6,558	D	$104.33	31,192	D
Common Stock - Restricted Stock Units								1,659.571(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (Right to Buy)	$32.83	12/01/2025		M			6,558	(3)	01/04/2026	Common Shares	6,558	$0	0	D
Phantom Stock Units (Deferred Compensation	(4)							(5)	(5)	Common Shares	1,976.605(2)		1,976.605	D

Explanation of Responses:

1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for financial planning purposes on February 10, 2025.

2. End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).

3. This option is presently exercisable in full.

4. Phantom stock units convert into common shares on a one-for-one basis.

5. Settlement of phantom stock units will be in Pentair common shares in accordance with reporting person's irrevocable election.

	/s/ John K. Wilson, Attorney-in-Fact for T. Michael Glenn	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Pentair (PNR) report on this Form 4?

The filing reports that a Pentair plc director exercised director stock options for 6,558 common shares at an exercise price of $32.83 per share and sold 6,558 common shares at a price of $104.33 per share on 12/01/2025.

Whose holdings are reported in this Pentair (PNR) Form 4 and what is their role?

The Form 4 covers a Pentair plc director, who is identified as a Director of the issuer and is filing as one reporting person. The signature block shows the form was signed by John K. Wilson, Attorney-in-Fact for T. Michael Glenn.

How many Pentair (PNR) shares does the director own after the reported transactions?

Following the reported transactions, the director beneficially owned 31,192 common shares directly and 1,659.571 common shares represented by restricted stock units. In addition, they held 1,976.605 phantom stock units, which are designed to convert into common shares on a one-for-one basis and be settled in Pentair common shares.

Was the Pentair (PNR) insider trade made under a Rule 10b5-1 plan?

Yes. The explanation states that the reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for financial planning purposes on February 10, 2025.

What derivative securities are disclosed for the Pentair (PNR) director on this Form 4?

The filing lists a director stock option (right to buy) with an exercise price of $32.83 that covered 6,558 common shares and was exercised on 12/01/2025, and phantom stock units (deferred compensation) tied to 1,976.605 common shares. The explanation notes that phantom stock units convert into common shares on a one-for-one basis and will be settled in Pentair common shares according to the reporting person’s irrevocable election.

Does the Pentair (PNR) Form 4 mention dividend reinvestment or exempt transactions?

Yes. The explanation notes that end-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions that are not required to be reported pursuant to Section 16(a).